Results 211 to 220 of about 259,206 (307)

Dopamine Transporter Imaging as Objective Monitoring Biomarker in Parkinson's Disease

open access: yesAnnals of Neurology, EarlyView.
Objective Although dopamine transporter (DaT) imaging is a valuable diagnostic biomarker, few studies have investigated its utility in objectively monitoring disease progression in patients with Parkinson's disease (PD). To date, no study has established a longitudinal relationship between the DaT signal decline and the motor symptom increase ...
Verena Dzialas   +4 more
wiley   +1 more source

Fast decay of iconic memory in observers with mild cognitive impairments [PDF]

open access: green, 2005
Zhong‐Lin Lu   +3 more
openalex   +1 more source

Mild Cognitive Impairment

open access: yesJournal of the Korean Neurological Association, 2016
Ae Young Lee, Eungseok Oh
openaire   +2 more sources

Mild cognitive impairment and subjective cognitive impairment [PDF]

open access: yesPsychogeriatrics, 2008
Toshihisa Tanaka   +4 more
openaire   +2 more sources

Neuroimaging Biomarkers for Friedreich Ataxia: A Cross‐Sectional Analysis of the TRACK‐FA Study

open access: yesAnnals of Neurology, EarlyView.
Objective We aimed to quantify differences in the brain and spinal cord between Friedreich ataxia and controls, stratified by age and disease stage, including for the first time in young children. Methods TRACK‐FA is the largest prospective, longitudinal, multi‐modal neuroimaging study in Friedreich ataxia to date.
Nellie Georgiou‐Karistianis   +33 more
wiley   +1 more source

Neuropsychological methods in mild cognitive impairment

open access: hybrid, 2004
Valérie Hahn‐Barma   +4 more
openalex   +1 more source

Apolipoprotein E and alpha brain rhythms in mild cognitive impairment: A multicentric Electroencephalogram study [PDF]

open access: green, 2005
Claudio Babiloni   +15 more
openalex   +1 more source

Mild Cognitive Impairment

open access: yes, 2018
Nazibrola Botchorishvili   +1 more
openaire   +4 more sources

Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center Cohort Study

open access: yesAnnals of Neurology, EarlyView.
Objective To compare clinical and radiological outcomes among relapsing multiple sclerosis patients treated with autologous hematopoietic stem cell transplantation (AHSCT), alemtuzumab (ATZ), and ocrelizumab (OCR). Methods From a London (UK) hospital‐based observational cohort, modeled data were obtained from 621 relapsing–remitting multiple sclerosis ...
Paolo Antonio Muraro   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy